Navigation Links
Nektar Therapeutics Reports Third Quarter 2011 Financial Results
Date:11/2/2011

181, a novel mu-opioid analgesic molecule wholly-owned by Nektar, is being evaluated in Phase 1 clinical studies.  In oncology, NKTR-102, a novel proprietary topoisomerase I-inhibitor, is being evaluated in Phase 2 clinical studies for the treatment of breast, ovarian and colorectal cancers.

Nektar's technology has enabled seven approved products in the U.S. or Europe through partnerships with leading biopharmaceutical companies, including UCB's Cimzia® for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS® for hepatitis C and Amgen's Neulasta® for neutropenia. Additional development stage products that leverage Nektar's proprietary technology platform include peginesatide, for which Affymax and partner Takeda submitted an NDA to the FDA in May 2011, and Baxter's BAX 855, a long-acting PEGylated rFVIII program planned to enter Phase 1 clinical development in 2011.

Nektar is headquartered in San Francisco, California, with additional R&D operations in Huntsville, Alabama and Hyderabad, India. Further information about the company and its drug development programs and capabilities may be found online at http://www.nektar.com.

This press release contains forward-looking statements including but not limited to Nektar's plans to initiate the Phase 3 BEACON study for NKTR-102 in metastatic breast cancer before year-end, plans to complete a Phase 1 clinical study for NKTR-181 and announce those results before year end, AstraZeneca's plans for regulatory filings in 2013, Baxter's plans to advance BAX 855 into Phase 1 clinical development prior to year end, Nektar's plan to file an investigational new drug application for NKTR-192 in the first quarter of 2012, and the value and potential of Nektar's R&D pipeline.  These forward-looking statements involve numerous risks and uncertainties, including but not limited to: (i) Nektar's product candidates and those of its collaborati
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Nektar Commences Phase 2 Clinical Development Program for NKTR-102 (PEG-Irinotecan) in Colorectal Cancer
2. Nektar Commences Phase 2 Trial of NKTR-118 (oral PEG-naloxol) Evaluating Efficacy and Safety as Treatment for Opioid-Induced Bowel Dysfunction
3. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
4. Nektar Therapeutics to Present Positive Data at Upcoming Medical and Scientific Meetings
5. Nektar to Webcast Presentation of Phase 1 Clinical Results for Lead Small Molecule PEG-Oncolytic Program, NKTR-102 (PEG-irinotecan)
6. Nektar Announces Expanded Phase 2 Clinical Development Plan For NKTR-102 (PEG-irinotecan)
7. Nektar Announces Positive Results from Phase 2 Study of Oral NKTR-118 in Patients with Opioid-Induced Constipation (OIC)
8. Nektar Therapeutics Reports Second Quarter 2009 Financial Results
9. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
10. Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer
11. Nektar Presents New Preclinical Data on NKTR-181 at Anesthesiology 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , September 4, 2015 Oramed ... a clinical-stage pharmaceutical company focused on the development of ... will participate in the upcoming Rodman & Renshaw 17 ... 8-10, 2015 in New York City ... will present a corporate overview on September 9, 2015. ...
(Date:9/4/2015)... Sep. 04, 2015 ... the addition of the "Pharmacovigilance (London, UK ... offering. Understanding PhV today - the ... working in Drug safety. This course ... with pharmacovigilance. New entrants as well as experienced ...
(Date:9/4/2015)... , Sep. 04, 2015 ... ) has announced the addition of the ... Market, 2010-2019" report to their offering. ... polymer containing repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. ... and cartilage matrix, sodium hyaluronate can lubricate ...
Breaking Medicine Technology:Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Pharmacovigilance Course: The Principles and Practice of Global PhV for those Working in Drug Safety (London, UK - December 7-9, 2015) 2Investigation Report on China's Sodium Hyaluronate Market 2015 2
... -- ADVANCE FOR RELEASE AT 5 P.M. EST MONDAY, ... Patients,who undergo complete prostate removal are less likely to ... done by an,experienced surgeon in a hospital that does ... the Agency for Healthcare Research and,Quality, part of the ...
... Regions of Body Consistent with Overall PASI ... Response in REMICADE-Treated Patients, SAN ANTONIO, ... placebo-controlled trials showed patients with moderate,to severe plaque psoriasis receiving ... each of the four body regions,(head, trunk, lower and upper ...
Cached Medicine Technology:Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior 2Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior 3Outcomes Vary for Prostate Cancer Patients Choosing Surgery; Overall, No Treatment Proven Superior 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 2REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 3REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 4REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 5REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 6REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 7REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 8REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 9REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body 10
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar announced today that ... of its Product, Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. , ... the consumer goods industry, it can be difficult for companies to navigate, stay ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... Keeping mold ... and around the home is quite common. Mold can grow anywhere - on carpet, ... leaking pipes. Checking for excessive moisture and water in the home is key to ...
(Date:9/4/2015)... TX (PRWEB) , ... September 04, 2015 , ... Mike ... Iraq in 2007, will compete in the Ironman World Championships in Kona on October ... who have incurred Traumatic Brain Injury (TBI) through combat and the cutting-edge treatments that ...
(Date:9/4/2015)... CA (PRWEB) , ... September 04, 2015 , ... The ... was ranked number 9 nationwide by Doximity. Faculty, residents and staff are ... take great pride in the quality of our ophthalmology residency program. Our faculty places ...
(Date:9/4/2015)... ... September 04, 2015 , ... ECC announces the ... created specifically for adults with intellectual, developmental and acquired disabilities. The first community, ... 30 cottage or “pocket” homes. In this community, adults will live safely and ...
Breaking Medicine News(10 mins):Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... Prop. D and E Seen as Destructive to Existing ... Medical Society,s board of directors has voted unanimously to ... will appear on the Special Election ballot of May ... programs, previously established by state voters, which are successfully ...
... May 5 Colgate and the Hispanic Dental,Association officially ... Mundo de,Sonrisas Saludables (Oral Health Month: A World of ... oral care among the Hispanic community.,The Latino population has ... other ethnicity and ranks the highest for untreated dental ...
... Derma Sciences (OTC Bulletin Board: ... today announced that it intended to voluntarily delist its common ... and that it would file Form 25 with the Securities ... effect this delisting.Ed Quilty, CEO of Derma Sciences, noted that, ...
... PreXion adds automated high-resolution panoramic imaging capability to ... PreXion 3D Viewer.SAN MATEO, Calif., May 5 ... in dental and industrial CT systems, today announced ... 3D CBCT scanner and the PreXion 3D Viewer, ...
... with elevated albumin levels were more likely to get ... News) -- A higher-than-normal level of the protein albumin ... clots in the deep veins of the lungs and ... (VTEs) include deep vein thrombosis (DVT), a clotting in ...
... disease, but there,s a promising new procedure being performed at Abington ... ... Abington, PA (PRWEB) May 5, 2009 -- There,s new ... Memorial Hospital where doctors are performing a procedure to bypass, ...
Cached Medicine News:Health News:Colgate Bright Smiles, Bright Futures(R) Kids' Initiative Visits Union City, NJ 2Health News:Derma Sciences Announces Voluntary Delisting from the Defunct Boston Stock Exchange 2Health News:PreXion Adds High-resolution Panoramic Imaging 2Health News:Urine Test Predicts Vein Clot Risk 2Health News:Urine Test Predicts Vein Clot Risk 3Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 2Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 3Health News:Unique Bypass is Rare, New Treatment for People with Severe Aortic Valve Stenosis 4
... computer-generated Thermal Printing Wristbands and Tags ... thermal and thermal transfer printers. Direct ... a heat-sensitive thermal coating under the ... use heat to transfer highly durable ...
A unique and cost effective one-piece adhesive closure patient bracelet with a tamper- resistant feature that has been designed for patient comfort, caregiver productivity, and long term durability....
... more secure band is desired for adults and where ... is appropriate. The design allows for two bands to ... placed on the wrist and the second to be ... replaced. This is particularly useful in a hospital situation ...
... ID system which combines the IDENTI-MATCH Blood Recipient ... six alert or warning ID bands. It is ... by hospital patients. It integrates the benefits of ... a multipurpose ID band that consolidates admitting and ...
Medicine Products: